PR96490

LONDON, June 14, 2022 /PRNewswire=KYODO JBN/ --

-- Funding round led by Advent Life Sciences. New investors include Emerson

Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala and the

Minderoo Foundation.

-- Proceeds to accelerate development and scale of Proximie's Operating System

for the Operating Room - a centralized platform delivering connected surgical

care

Proximie ( https://proximie.com/ ), the global health technology platform

digitally connecting operating rooms (OR) announces it has successfully raised

$80 million in a Series C equity financing. The investment follows a year in

which Proximie saw a significant increase in its Total Contracted Value,

supported over 13,000 surgeries, and expanded their global footprint to 100

countries.

Photo - https://mma.prnewswire.com/media/1838600/Proximie_in_action_OR.jpg

Photo -

https://mma.prnewswire.com/media/1838599/Dr_Nadine_Hachach_Haram_headshot.jpg

The funding round was led by Advent Life Sciences - one of the leading

trans-Atlantic venture investors building innovative life sciences businesses,

with participation from new investors Emerson Collective - the impact investor

founded by Laurene Powell Jobs, SoftBank Vision Fund 2, British Patient

Capital, Mubadala Investment Company, and the Minderoo Foundation. Existing

investors F-Prime Capital, Eight Roads, Questa Capital, Global Ventures, and

Maverick Ventures also participated in the round.

Proceeds will be used to accelerate development of key products and services,

build out Proximie's marketplace ecosystem and scale their Operating System of

the OR - a centralized platform delivering connected surgical care. Hospitals

and surgical centers who leverage Proximie's technology will have access to

preoperative data that can help inform patient care, real time collaborative

tools to record, train, and deliver care, and postoperative content management

tools to capture and distribute content to their colleagues. Taken together,

Proximie will allow health systems to establish an intelligent, digital layer

to the OR, enabling them to save time, money, and more lives.

Proximie has been used for cases in surgical specialities at over 500 hospitals

worldwide. Hospitals have applied Proximie's technology to drive efficiencies

in the surgical backlog following COVID-19, increased the speed of training

surgeons while maintaining costs, and built hub and spoke models concentrating

surgical care and expertise in central locations to reduce the time and costs

associated with travel.

Dr. Nadine Hachach-Haram, CEO and Founder of Proximie, said:

"Our vision is to democratize surgery through better data by connecting every

OR and Cath Lab in the world.  We began this journey enabling surgeons to

virtually join any OR.  Now, we're using this capability to digitize the

operating room, bringing patients the collective expertise of the best surgeons

in the world - where data collected and shared on Proximie can help them

receive life-saving care, no matter where they live."

Five billion people currently lack access to safe surgery, with over 18 million

people dying every year from lack of access to surgery. Launched in 2016,

Proximie is a tool allowing surgeons to virtually "scrub in" to any operating

room in the world, extending the capabilities of top surgeons to areas without

access to top surgical care. With the COVID-19 pandemic inhibiting travel and

access, Proximie has grown rapidly, scaling to five continents and over 100

countries, helping surgeons deliver lifesaving care during a time of healthcare

disruption.

Dr. Shahzad Malik, General Partner Advent Life Sciences, said:

"We are delighted to partner with Proximie and a world class group of investors

as the company expands its global footprint and product capabilities. The

company is a perfect fit for our ethos of backing best-in-class innovative life

sciences businesses that have the capability to positively impact human health

and healthcare delivery in paradigm changing ways."

The successful completion of today's fundraise means Proximie has raised a

total of $130 million since inception.

John Cassidy, Investment Director at SoftBank Investment Advisers said:

"The pandemic has rapidly accelerated the adoption of virtual clinical care

globally. Proximie's technology platform combines AI, machine learning, and

augmented reality to facilitate live sharing of the operating room, creating a

connected surgical care ecosystem to better support patients and hospitals. We

are pleased to partner with Dr. Nadine Hachach-Haram and the Proximie team to

support their mission of saving lives by sharing the world's best clinical

practices."

Notes to Editors

About Proximie

    -- Proximie is a global health technology platform focused on digitizing

       operating and diagnostic rooms;

    -- Proximie's mission is to deliver a connected surgical platform to help

       provide quality surgical care around the globe. Every Proximie

       procedure can be recorded, analysed and leveraged for future use to

       help inform best practice;

    -- By connecting operating rooms globally, Proximie is facilitating a

       rich, insightful data set which naturally feeds best practices into

       the entire healthcare ecosystem;

    -- Founded by Dr Nadine Hachach-Haram, Proximie has now conducted tens of

       thousands of surgical procedures and been deployed in over 500

       hospitals in across 100 countries in five continents;

    -- Proximie has contracts with over 35 major medical device companies –

       with access to 90% of operating rooms and diagnostic suites in the

       U.K., U.S., and E.U – and been published in over 20 medical journals;

    -- For more information please visit www.proximie.com or

       follow @ProximieAR

       (

https://twitter.com/ProximieAR?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

)

        on Twitter.

About Advent Life Sciences

    -- Advent Life Sciences founds and invests in early- and mid-stage life

       sciences companies that have a first- or best-in-class approach to

       unmet medical needs

    -- The investment team consists of experienced professionals, each with

       extensive scientific, medical and operational experience, and a long-

       standing record of entrepreneurial and investment success in the US

       and Europe

    -- The firm invests in a range of sectors within life sciences, including

       drug discovery, enabling technologies, digital health, and med tech,

       with an emphasis on innovative, paradigm-changing approaches

    -- Advent Life Sciences has a presence in the UK, US and France

    -- For more information, please visit www.adventls.com　

SOURCE Proximie